Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes
Clinical trial NCT01647308 · TERMINATED
Trial details
- NCT number
- NCT01647308
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.